SELE and rheumatoid arthritis: This is an attractive therapeutic target in autoimmune inflammatory diseases such as rheumatoid arthritis and psoriasis in which the expression of E-selectin has been shown to be responsible for the pathological accumulation of active immune cells such as lymphocytes (8, 68).